Loading stock data...

Raaj Medisafe India Limited

BSE: RAAJMEDI

BSE
85.99 0.35 (0.41%)

Prev Close

85.64

Open Price

85

Volume

200

Today Low / High

85 / 85.99

52 WK Low / High

64.08 / 102.35

Range

82 - 90

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 85.99, reflecting a change of 0.35 (0.40869%). The expected target range on the BSE is 82 - 90. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

18 Feb 85.00 1.16%
17 Feb 90.01 -4.86%
16 Feb 89.01 0.00%
13 Feb 92.45 -3.00%
12 Feb 90.00 4.71%
09 Feb 90.00 0.00%
06 Feb 86.00 5.81%
05 Feb 94.01 -4.00%
04 Feb 92.51 2.68%
02 Feb 91.30 0.00%
01 Feb 96.00 0.00%
30 Jan 86.99 5.76%
29 Jan 84.00 4.96%
28 Jan 83.98 0.00%

Raaj Medisafe India Limited Graph

Raaj Medisafe India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Raaj Medisafe India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 85.99, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 85.99 86.85 78.16 - 95.53
87.71 70.17 - 105.25
88.57 62.00 - 115.14
Bearish Scenario 85.99 85.13 76.62 - 93.64
84.27 67.42 - 101.12
83.41 58.39 - 108.43

Overview of Raaj Medisafe India Limited

ISIN

INE548H01015

Industry

Medical - Specialties

Vol.Avg

3,046

Market Cap

1,136,556,659

Last Dividend

0

Official Website

Visit Website

IPO Date

2011-11-18

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for RAAJMEDI

Metric Value Recommendation
Overall Rating B Neutral
DCF Score 1 Strong Sell
ROE Score 5 Strong Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 62.42 Cr 43.78 Cr 18.64 Cr 0.2986 0.00 Cr 3.99 Cr 7.18 Cr 6.13 Cr 4.60 8.83 Cr 0.0982
2024-03-31 43.25 Cr 31.63 Cr 11.62 Cr 0.2686 0.00 Cr 0.51 Cr 5.78 Cr 3.33 Cr 3.05 6.58 Cr 0.0770
2023-03-31 38.62 Cr 28.98 Cr 9.64 Cr 0.2497 0.00 Cr 0.48 Cr 4.87 Cr 3.33 Cr 3.06 5.61 Cr 0.0862
2022-03-31 34.69 Cr 25.28 Cr 9.42 Cr 0.2714 0.00 Cr 0.96 Cr 4.37 Cr 3.01 Cr 2.82 5.11 Cr 0.0868
2021-03-31 31.81 Cr 24.00 Cr 7.80 Cr 0.2453 0.00 Cr 0.32 Cr 3.38 Cr 2.30 Cr 2.07 4.06 Cr 0.0723

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.05 Cr 69.22 Cr 42.30 Cr 26.9154 Cr 34.57 Cr 34.52 Cr 8.14 Cr 31.57 Cr 0.00 Cr 0.00 Cr 0.07 Cr 27.8675 Cr
2024-03-31 0.03 Cr 41.51 Cr 30.67 Cr 10.8367 Cr 25.87 Cr 25.84 Cr 8.46 Cr 21.02 Cr 0.00 Cr 0.00 Cr 0.07 Cr 16.1088 Cr
2023-03-31 0.01 Cr 25.77 Cr 18.28 Cr 7.4908 Cr 15.61 Cr 15.60 Cr 6.61 Cr 10.26 Cr 0.00 Cr 0.00 Cr 0.07 Cr 11.3207 Cr
2022-03-31 0.02 Cr 19.62 Cr 15.47 Cr 4.1492 Cr 13.01 Cr 12.99 Cr 3.11 Cr 9.30 Cr 0.00 Cr 0.00 Cr 0.11 Cr 9.5061 Cr
2021-03-31 0.01 Cr 16.61 Cr 15.54 Cr 1.0720 Cr 13.13 Cr 13.11 Cr 1.65 Cr 8.86 Cr 0.00 Cr 0.00 Cr 0.07 Cr 6.5266 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.0868 Cr -16.4170 Cr 16.5233 Cr -14.7964 Cr 0.0195 Cr 0.0649 Cr -14.7096 Cr 5.1920 Cr 8.6414 Cr 0.0000 Cr 0.3216 Cr
2024-03-31 4.2749 Cr -13.0006 Cr 8.7434 Cr -7.3641 Cr 0.0177 Cr 0.0442 Cr -11.6390 Cr 4.3057 Cr 10.3084 Cr 0.0000 Cr -1.8528 Cr
2023-03-31 0.1740 Cr -1.6652 Cr 1.4854 Cr -1.5520 Cr -0.0058 Cr 0.0265 Cr -1.7260 Cr 3.7826 Cr 2.6007 Cr 0.0000 Cr -3.5029 Cr
2022-03-31 2.4452 Cr -0.9614 Cr -1.4664 Cr 1.2348 Cr 0.0174 Cr 0.0323 Cr -1.2104 Cr 3.7274 Cr -0.7518 Cr 0.0000 Cr -1.5864 Cr
2021-03-31 2.2284 Cr -2.7800 Cr 0.5133 Cr -1.6602 Cr -0.0383 Cr 0.0149 Cr -3.8886 Cr 2.5802 Cr 1.2578 Cr 0.0000 Cr -0.6512 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 18.40 Cr 11.87 Cr 6.54 Cr 0.3552 2.31 Cr 1.73 Cr 1.32 2.98 Cr 0.0938
2025-06-30 15.83 Cr 10.07 Cr 5.75 Cr 0.3636 2.14 Cr 1.46 Cr 1.11 2.63 Cr 0.0923
2025-03-31 24.40 Cr 18.50 Cr 5.90 Cr 0.2417 2.67 Cr 3.48 Cr 2.58 3.22 Cr 0.1426
2024-12-31 14.59 Cr 9.27 Cr 5.32 Cr 0.3649 1.81 Cr 1.03 Cr 0.76 2.20 Cr 0.0703
2024-09-30 12.52 Cr 8.60 Cr 3.93 Cr 0.3136 1.19 Cr 0.65 Cr 0.49 1.67 Cr 0.0521

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.23 Cr 0.52 Cr 0.75 Cr 10.30 Cr 8.74 Cr 35.08 Cr 45.35 Cr 89.14 Cr 60.03 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.06 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -26.92 Cr
2025-03-31 0.05 Cr 0.01 Cr 0.06 Cr 16.70 Cr 8.14 Cr 29.62 Cr 31.57 Cr 69.22 Cr 42.30 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -22.47 Cr
2024-09-30 0.15 Cr 0.01 Cr 0.16 Cr 8.58 Cr 11.90 Cr 26.35 Cr 27.65 Cr 58.02 Cr 35.55 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 3.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.97 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Managing Director & Chairman
Arpit Bangur

Gender: male

Year Born: 1987

Joint MD & Executive Director
Navin Jhawar

Gender: male

Year Born: 1981

Company Secretary & Compliance Officer
Sachin Sarda

Gender: male

Year Born:

Chief Financial Officer
Fatima Dadani

Gender: female

Year Born:

FAQs about Raaj Medisafe India Limited

Who is the CEO of the company?

The CEO is Arpit Bangur.

What is the current market price of the stock?

The current price is ₹85.99.

What is the 52-week price range?

The range is ₹64.08-102.35.

What is the market capitalization of the company?

The market capitalization is ₹113.66 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 14.62.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Raaj Medisafe India Limited (ISIN: INE548H01015) is a leading Medical - Specialties in India. With a market capitalization of ₹113.66 crores and an average daily volume of 3,046 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.